27 /100
MEDIUM RISK
Score updated May 30, 2026

NAVI — Navient Corporation Dilution Risk Tracker

Track NAVI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NAVI — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for NAVI.
🔔 Track NAVI — Get forecast alerts →

💹 Market Data

Market Cap$804.55M
Shares Outstanding93.99M
Float62.32M
Cash$657.00M
Debt$45.20B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 29.2% shares (2026Q1 vs prior)
238 institutional holders · 72.29M shares
#1 Sherborne Investors Management LP 29.45M shares
#2 BlackRock, Inc. 11.50M shares
#3 DIMENSIONAL FUND ADVISORS LP 7.96M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest9.62M
Days to Cover9.4
% of Float15.4%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Dec 31, 2025
13F-HR BENEFICIAL OWNERSHIP Sep 30, 2025
13F-HR BENEFICIAL OWNERSHIP Sep 30, 2025
13F-HR BENEFICIAL OWNERSHIP Sep 30, 2025
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track NAVI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NAVI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for NAVI
📊 NAVI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NAVI Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.